The California Future of Abortion Council (CA FAB Council) steering committee released the following statement in response to the U.S. District Court for the Northern District of Texas’ decision in Alliance for Hippocratic Medicine v. FDA, which issued a preliminary injunction suspending the Food and Drug Administration’s approval of the abortion medication Mifepristone dating back to 2000.
“The California Future of Abortion Council Steering Committee denounces the ruling in Alliance for Hippocratic Medicine v. FDA. The recent attacks on mifepristone, one of the two medications typically used in a medication abortion, are an alarming development in the ongoing efforts by right-wing extremists to restrict access to abortion in the United States, including in states with robust policies to protect and expand access to abortion care. The California Future of Abortion Steering Committee rejects these attacks and will continue to fight to protect the rights and health of every person in California and those that seek abortion care in our state. Despite this ruling, we want to be exceedingly clear—abortion care will remain legal and available here in California. The CA FAB Council will continue to work with legislative partners to develop and implement policies that protect access to abortion.”
The California Future of Abortion Council steering committee is a joint project of ACCESS REPRODUCTIVE JUSTICE, Black Women for Wellness Action Project (BWWAP), California Coalition for Reproductive Freedom, California Latinas for Reproductive Justice (CLRJ), Essential Access Health, NARAL Pro-Choice California, National Health Law Program, Planned Parenthood Affiliates of California, and TEACH (Training in Early Abortion for Comprehensive Healthcare)
Comments